Skip to main content

UBS Group AG

Position in RNAZ — Transcode Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in RNAZ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,934
-$53,485 QoQ
Shares Held
2,888
-65.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 8 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. RNAZ ranks #428 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNAZ

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,934 2,888
2026-03-31 $71,419 8,295
2025-12-31 $20,243 2,964
2025-06-30 $11,168 1,432
2025-03-31 $130,644 263,929
2024-12-31 $29,238 8,676
2024-06-30 $75,298 74,924
2023-12-31 $1,299 7,874
2023-09-30 $73,704 146,530
2022-12-31 $780 1,159
2022-03-31 3,973
2021-12-31 5,254
2021-09-30 5,337